A carregar...
A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection
BACKGROUND: Data from studies in nonhuman primates suggest that the triple monoclonal antibody cocktail ZMapp is a promising immune-based treatment for Ebola virus disease (EVD). METHODS: Beginning in March 2015, we conducted a randomized, controlled trial of ZMapp plus the current standard of care...
Na minha lista:
| Publicado no: | N Engl J Med |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5086427/ https://ncbi.nlm.nih.gov/pubmed/27732819 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1604330 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|